To investigate the cellular response occurring after the acquisition of resistance to EGFR tyrosine kinase inhibitors (TKIs) in lung cancer, we generated a gefitinib‐resistant cell line using EGFR‐mutant HCC827 cells. The gene discussed is EGFR; the disease is lung cancer.